Unraveling Resistance Mechanisms to the Novel Nucleoside Analog RX-3117 in lung cancer: Insights into DNA Repair, Cell Cycle Dysregulation and Targeting PKMYT1 for Improved Therapy

ABSTRACT: Unraveling Resistance Mechanisms to the Novel Nucleoside Analog RX-3117 in lung cancer: Insights into DNA Repair, Cell Cycle Dysregulation and Targeting PKMYT1 for Improved Therapy

PROVIDER: PRJNA1282678 | ENA |

REPOSITORIES: ENA